Curriculum · Metabolic and Endocrine and Diabetes Mellitus
Basal-bolus insulin regimen and dose adjustment
What it is
The basal-bolus regimen is considered the best for the day-to-day management of diabetes: a long acting basal insulin at night with rapid insulin at meals. It is similar to physiological insulin, which exists at a baseline level with insulin spikes after a meal. Insulin therapy for people with type 1 diabetes should be based on basal and bolus insulin therapy called Multiple Daily Injections, or on basal plus bolus insulin based on the Insulin Carbohydrate Ratio, or on insulin pump therapy.
How it is treated
In a basal-bolus regimen it is important to remember that blood sugar measurements are affected by the prior insulin dose. So the adjustment runs two ways: 1) if the AM glucose measurement is high, increase the nighttime insulin dose; 2) if the lunchtime glucose is high, increase the breakfast dose. In the inpatient setting, sliding scale insulin can be added to an existing basal-bolus regimen; it allows extra insulin to be given if blood sugar is high, which is then added back onto the total daily insulin requirement for the following day.
In diabetic ketoacidosis and the hyperglycemic hyperosmolar state the regimen begins with an initial continuous IV insulin infusion, alongside high-flow 0.9% normal saline, with dextrose 5% added when the serum glucose is 200 mg/dL or below. The switch to subcutaneous basal-bolus insulin is made on four conditions together: the patient is able to eat, the glucose is below 200 mg/dL, the anion gap is below 12 mEq/L, and the serum HCO3 is 15 mEq/L or above. The subcutaneous and IV insulin are overlapped by 1-2 hours. Potassium is managed against two cut points: IV potassium is added when the serum K+ is 5.2 mEq/L or lower, and insulin is held while the serum K+ is below 3.3 mEq/L. Nearly all patients are potassium depleted, even with hyperkalemia. Bicarbonate is considered for a pH below 6.9, and phosphate for a serum phosphate below 1.0 mg/dL, cardiac dysfunction or respiratory depression, with frequent monitoring of serum calcium.
When the patient fasts, the bolus insulin is not treated the same way at every meal. For rapid- or short-acting prandial bolus insulin the dose is decreased: take normal dose at iftar, omit lunch dose, and decrease suhoor dose by 25-50%, so what was three doses at meals goes down to two, and it is the lunch dose that goes. Long- or intermediate-acting basal insulin taken OD is taken at iftar with the dose decreased by 15-30%, and where it is BID the usual morning dose is taken at iftar while the evening dose is decreased by 50% and taken at suhoor. Insulin dose titration should be performed every three days and dose adjustments made according to BG levels: decrease by 4 units below 3.9 mmol/L or with symptoms, decrease by 2 units at 3.9-5.0 mmol/L, no change at 5.0-7.0 mmol/L, increase by 2 units at 7.0-11.1 mmol/L and increase by 4 units above 11.1 mmol/L.